Skip to content

Clinical trials

Phase 3 Dyspepsia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyspepsia Phase: Phase 3 Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20049
20053
20073
20082
20091
20102
20121
20134
20141
20151
20161
20172
20201
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Unknown status2
Active, not recruiting1
Terminated1
Withdrawn1
Recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis6
Forest Laboratories4
AstraZeneca3
Chinese University of Hong Kong3
EMS2
RedHill Biopharma Limited2
59th Medical Wing1
Astellas Pharma Inc1
Cogentus Pharmaceuticals1
Eisai China Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyspepsia36
Gastroesophageal Reflux6
Heartburn4
Constipation3
Gastrointestinal Diseases3
Signs and Symptoms, Digestive3
Abdominal Pain2
Digestive System Diseases2
Nausea2
Acute Coronary Syndrome1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.